We are live on !
Find out more
Meriwether Wealth & Planning Portfolio holdings
AUM
$222M
Turnover
86.27%
1-Year Est. Return
15.77%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+15.77%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$222M
AUM Growth
+$19.9M
(+9.8%)
Cap. Flow
+$21.6M
Cap. Flow % of AUM
Cap. Flow %
9.74%
Top 10 Holdings %
Top 10 Hldgs %
51.95%
Holding
874
New
752
Increased
41
Reduced
65
Closed
2
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck IG Floating Rate ETF
FLTR
|
+$8.22M |
| 2 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$1.15M |
| 3 |
Schwab US Large-Cap Value ETF
SCHV
|
+$984K |
| 4 |
Vanguard Total International Stock ETF
VXUS
|
+$856K |
| 5 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$563K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity Total Bond ETF
FBND
|
+$6.27M |
| 2 |
ExxonMobil
XOM
|
+$5.31M |
| 3 |
RTX Corp
RTX
|
+$295K |
| 4 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
+$225K |
| 5 |
Bank of New York Mellon
BNY
|
+$202K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 62.64% |
| 2 | Technology | 8.59% |
| 3 | Financials | 7.31% |
| 4 | Healthcare | 4.35% |
| 5 | Consumer Discretionary | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Canadian Pacific Kansas City
CP
$79.7B
| $731K | 0.33% |
8,586
| – | – |
2024 Q4
7 quarters
|
|
52
Novartis
NVS
$297B
| $715K | 0.32% |
5,017
-1,117
| -18% | -$169K |
2024 Q4
7 quarters
|
|
53
McKesson
MCK
$118B
| $707K | 0.32% |
828
-8
| -1% | -$6.88K |
2024 Q4
7 quarters
|
|
54
Palantir
PLTR
$471B
| $703K | 0.32% |
3,758
-146
| -4% | -$23.3K |
2024 Q4
7 quarters
|
|
55
Alphabet (Google) Class A
GOOGL
$3.97T
| $684K | 0.31% |
1,987
-8
| -0.4% | -$2.78K |
2024 Q4
7 quarters
|
|
56
Accenture
ACN
$158B
| $660K | 0.3% |
3,602
-4
| -0.1% | -$676 |
2026 Q1
2 quarters
|
|
57
AbbVie
ABBV
$504B
| $652K | 0.29% |
2,493
+55
| +2% | +$14.1K |
2024 Q4
7 quarters
|
|
58
TSMC
TSM
$2.14T
| $622K | 0.28% |
1,364
-38
| -3% | -$16.1K |
2024 Q4
7 quarters
|
|
59
Invesco BulletShares 2027 High Yield Corporate Bond ETF
BSJR
$944M
| $609K | 0.27% |
27,550
-1,835
| -6% | -$41K |
2024 Q4
7 quarters
|
|
60
Schwab US Dividend Equity ETF
SCHD
$118B
| $604K | 0.27% |
18,581
-460
| -2% | -$15.5K |
2024 Q4
7 quarters
|
|
61
KLA
KLAC
$193B
| $567K | 0.26% |
2,910
-73
| -2% | -$14.3K |
2024 Q4
7 quarters
|
|
62
Thermo Fisher Scientific
TMO
$250B
| $550K | 0.25% |
815
-10
| -1% | -$5.94K |
2026 Q1
2 quarters
|
|
63
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
| $546K | 0.25% |
6,977
+230
| +3% | +$18.6K |
2024 Q4
7 quarters
|
|
64
Invesco BulletShares 2026 High Yield Corporate Bond ETF
BSJQ
$705M
| $537K | 0.24% |
23,509
-1,730
| -7% | -$39.6K |
2024 Q4
7 quarters
|
|
65
Jackson Financial
JXN
$9.03B
| $524K | 0.24% |
4,050
| – | – |
2024 Q4
7 quarters
|
|
66
Tesla
TSLA
$1.48T
| $499K | 0.23% |
1,407
-57
| -4% | -$20.4K |
2024 Q4
7 quarters
|
|
67
Ferguson
FERG
$44B
| $498K | 0.22% |
2,235
+784
| +54% | +$182K |
2026 Q1
2 quarters
|
|
68
Eli Lilly
LLY
$1.16T
| $493K | 0.22% |
426
+1
| +0.2% | +$1.18K |
2024 Q4
7 quarters
|
|
69
Eventide US Market ETF
ESUM
$200M
| $485K | 0.22% |
16,025
+1,446
| +10% | +$44.2K |
2025 Q4
3 quarters
|
|
70
Tyler Technologies
TYL
$16.1B
| $478K | 0.22% |
1,500
| – | – |
2025 Q4
3 quarters
|
|
71
Intuitive Surgical
ISRG
$157B
| $458K | 0.21% |
1,126
-109
| -9% | -$41.6K |
2024 Q4
7 quarters
|
|
72
PepsiCo
PEP
$189B
| $453K | 0.2% |
3,577
+1,081
| +43% | +$149K |
2024 Q4
7 quarters
|
|
73
Amgen
AMGN
$242B
| $449K | 0.2% |
1,066
+40
| +4% | +$15.9K |
2024 Q4
7 quarters
|
|
74
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$775M
| $436K | 0.2% |
20,376
-1,884
| -8% | -$40.9K |
2024 Q4
7 quarters
|
|
75
Aon
AON
$65.1B
| $413K | 0.19% |
1,492
-9
| -0.6% | -$3.04K |
2026 Q1
2 quarters
|
|
Similar funds
HCA
LCM
WA1
Meriwether Wealth & Planning's Q3 2026 Portfolio in Review
As of Q3 2026, Meriwether Wealth & Planning held 874 positions worth $222M, up 9.8% from $202M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Meriwether Wealth & Planning deployed $21.6M of net new capital in Q3 2026, opening 752 new positions and adding to 41 existing holdings. Its largest new stake was VanEck IG Floating Rate ETF: 321,687 shares worth $8.23M.
By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, down from 64% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Fidelity Total Bond ETF, an estimated $6.27M trimmed.
- Meriwether Wealth & Planning's largest Q3 2026 buy was VanEck IG Floating Rate ETF: 321,687 shares worth $8.23M.
- Meriwether Wealth & Planning added most to Schwab US Large-Cap Growth ETF in Q3 2026, an estimated $1.15M increase.
- Meriwether Wealth & Planning's biggest Q3 2026 reduction was Fidelity Total Bond ETF, cutting an estimated $6.27M.
- Meriwether Wealth & Planning fully exited ExxonMobil in Q3 2026, selling an estimated $5.31M.
- Meriwether Wealth & Planning's ten largest holdings make up 52% of its $222M portfolio in Q3 2026.
- Meriwether Wealth & Planning opened 752 new positions and closed 2 in Q3 2026.
- Meriwether Wealth & Planning's portfolio value rose 9.8% quarter-over-quarter to $222M.
Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.